[<sup>64</sup>Cu]Cu-DOTA-TYPE7: a targeted PET radiotracer for imaging EphA2+ tumors. [PDF]
Sanwick AM +4 more
europepmc +1 more source
Cassette-Based Automated Production of 2-Deoxy-2-[<sup>18</sup>F]fluorocellobiose on the Trasis AllInOne with Undetectable [<sup>18</sup>F]FDG Contamination. [PDF]
Basuli F +5 more
europepmc +1 more source
Synthesis of [<sup>18</sup>F]rufinamide as a radiotracer for epileptic brain imaging. [PDF]
Pandey V, Faheem M, Gambhir S, Dixit M.
europepmc +1 more source
[<sup>161</sup>Tb]Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution Insights. [PDF]
Radović M +8 more
europepmc +1 more source
Implementation of positron emission tomography radiopharmaceuticals labeled with Gallium-68 in a hospital radiopharmacy: experience with more than 7,500 patients. [PDF]
Yamaga LYI +11 more
europepmc +1 more source
Preclinical and First-In-Human Evaluation of <sup>68</sup>Ga-PSMA-33, a Novel PSMA Radiotracer with Low Background Signal. [PDF]
Wu W +17 more
europepmc +1 more source
Combined antitumor activity of [<sup>177</sup>Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein. [PDF]
Tseng JR +7 more
europepmc +1 more source
Porous hydroxyapatite microparticles loaded with <sup>169</sup>Er for treatment of chronic inflammatory disease of small joints: harnessing mechanochemistry for synthesis of an advanced biomaterial. [PDF]
Patra S +9 more
europepmc +1 more source
A novel <sup>18</sup>F-labelled tetrazine ester prosthetic group for improved radiolabelling and in vivo stability of proteins and peptides. [PDF]
Lechi F +5 more
europepmc +1 more source
Scale-up production of [211At]PSMA-5 using automated synthesizer for Investigator-Initiated clinical trial. [PDF]
Naka S +13 more
europepmc +1 more source

